Showing 241 - 260 results of 100,734 for search '(( 5 point decrease ) OR ( 5 ((((nm decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.63s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246

    Decreased FA number in Rgnef−/− MEFs on fibronectin (FN) at 90 min. by Nichol L. G. Miller (162752)

    Published 2012
    “…Paxillin-stained points were enumerated as FAs by thresholding images using Image J (v1.4) and FA size (pixels) was determined using Cell Profiler (v2.0). …”
  7. 247

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”
  8. 248
  9. 249

    Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

    Published 2016
    “…Knockdown of C9orf72 significantly decreased p-S6K1 levels compared with cells treated with control shRNA (n = 3, *<i>p</i><0.5). …”
  10. 250
  11. 251

    IgG-mediated systemic anaphylaxis decreased in BasoDTR mice. by Kunie Matsuoka (400418)

    Published 2013
    “…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256
  17. 257
  18. 258
  19. 259

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”
  20. 260